Catalyst Wire Dossier Catalyst Wire Dossier

glulisine

glulisine
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for glulisine, covering 2019-09-10 to 2020-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease [Phase 2]

See pricing